The drought has dried up water supplies in some parts of the country — and water wars are heating up, between farmers and cities. In New Mexico, farmers have kicked off what could be a long-running fight by making a “priority call” on water resources.
Biogen Idec, a Massachusetts-based biotech company, is hoping its new multiple sclerosis drug Tecfidera will eventually bring in the hundreds of millions of dollars it cost to develop — at least before a generic comes along and copies it. CEO George Scangos joined Marketplace Morning Report host Jeremy Hobson to discuss his company’s development process and pricing strategy.
Stories You Might Like
There’s a lot happening in the world. Through it all, Marketplace is here for you.
You rely on Marketplace to break down the world’s events and tell you how it affects you in a fact-based, approachable way. We rely on your financial support to keep making that possible.
Your donation today powers the independent journalism that you rely on. For just $5/month, you can help sustain Marketplace so we can keep reporting on the things that matter to you.
